Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Rockwell Medical Technologies Inc (RMTI)  
$0.22 0.00 (0.00%) as of 4:30 Thu 5/12


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 9,411,000
Market Cap: 2.03(M)
Last Volume: 2,864,142 Avg Vol: 937,479
52 Week Range: $0.2158 - $0.2158
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Appliances & Equipment

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Rockwell Medical is a commercial-stage, biopharmaceutical company developing and commercializing its parenteral iron technology platform, Ferric Pyrophosphate Citrate (FPC). Co. is also a supplier of hemodialysis concentrate products to kidney dialysis clinics in the U.S. Co. has two therapies, Triferic and Triferic AVNU, which are developed from its FPC platform. Co. markets both products to kidney dialysis centers for their patients receiving dialysis. Co. has filed an Investigational New Drug Application to conduct a Phase II trial for the treatment of iron deficiency anemia in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 171
  Page 7 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gupta Ajay Chief Scientific Officer   •       –      –    2015-07-07 4 GD $0.00 $0 D/D 10,000 321,667     -
   Gupta Ajay Chief Scientific Officer   •       –      –    2015-06-12 4 GD $0.00 $0 D/D 15,000 331,667     -
   Klema Thomas E Vice President, CFO   •       –      –    2015-05-01 4 D $9.64 $264,522 D/D (27,440) 494,740     -
   Chioini Robert L Chairman, President and CEO   •       •      –    2015-05-01 4 D $9.64 $705,648 D/D (73,200) 1,783,933     -
   Pratt Raymond Dennis VP of Drug Development   •       –      –    2015-05-01 4 D $9.64 $334,026 D/D (34,650) 155,700     -
   Gupta Ajay Chief Scientific Officer   •       –      –    2015-05-01 4 D $9.64 $145,063 D/D (15,048) 346,667     -
   Pratt Raymond Dennis VP of Drug Development   •       –      –    2015-03-02 4 D $10.47 $362,786 D/D (34,650) 190,350     -
   Gupta Ajay Chief Scientific Officer   •       –      –    2015-03-02 4 D $10.47 $329,805 D/D (31,500) 361,715     -
   Klema Thomas E Vice President, CFO   •       –      –    2015-03-02 4 D $10.47 $287,297 D/D (27,440) 522,180     -
   Chioini Robert L Chairman, President and CEO   •       •      –    2015-03-02 4 D $10.47 $483,714 D/D (46,200) 1,857,133     -
   Chioini Robert L Chairman, President and CEO   •       •      –    2014-12-22 4 D $8.56 $2,225,600 D/D (260,000) 1,903,333     -
   Chioini Robert L Chairman, President and CEO   •       •      –    2014-12-22 4 OE $2.79 $934,650 D/D 335,000 2,163,333     -
   Boyd Ronald D Director   –       •      –    2014-12-18 4/A OE $2.79 $34,875 D/D 12,500 17,500     -
   Boyd Ronald D Director   –       •      –    2014-12-18 4 OE $2.79 $34,875 D/D 12,500 12,500     -
   Klema Thomas E Vice President, CFO   •       –      –    2014-12-17 4 D $8.32 $478,400 D/D (57,500) 549,620     -
   Klema Thomas E Vice President, CFO   •       –      –    2014-12-17 4 OE $2.79 $160,425 D/D 57,500 607,120     -
   Pratt Raymond Dennis VP of Drug Development   •       –      –    2014-10-01 4 A $0.00 $0 D/D 75,000 225,000     -
   Klema Thomas E Vice President, CFO   •       –      –    2014-10-01 4 A $0.00 $0 D/D 70,000 549,620     -
   Gupta Ajay Chief Scientific Officer   •       –      –    2014-10-01 4 OE $6.74 $87,620 D/D 13,000 393,215     -
   Gupta Ajay Chief Scientific Officer   •       –      –    2014-10-01 4 A $0.00 $0 D/D 75,000 380,215     -
   Chioini Robert L Chairman, President and CEO   •       •      –    2014-10-01 4 A $0.00 $0 D/D 200,000 1,828,333     -
  171 Records found
  1  2  3  4  5  6  7    
  Page 7 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us